Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
QSI
QSI | US
0.79
USD0.05
6.51%
QSI | US
About QSI
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
13/04/2026
Close
0.79
Open
0.73
High
0.79
Low
0.72
Quantum-Si incorporated a life sciences company engages in the development of protein detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Carbon automated sample preparation instrument; the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip; the Quantum-Si Cloud data analysis software; and reagent kits for use with its instruments. The company was founded in 2013 is based in Guilford Connecticut.
View LessQSI | US
Risk
62.9
Sharpe
-0.43
Luna's Score
52/100
Recommendation
Hold
Luna says (QSI | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
60.7%1 month
62.9%3 months
75.1%6 months
90.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.48
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
0.63
Ent. to rev.
14.41
PEG
-
Other Fundamentals
EBITDA
-95.52M
MarketCap
112.28M
MarketCap(USD)
112.28M
Div. yield
-
Op. margin
-4.25K
Erngs. growth
-
Rev. growth
203.40
Ret. on equity
-32.58
Short ratio
13.58
Short perc.
7.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.10
Range1M
0.29
Range3M
0.64
Volumes: Market Activity
Rel. volume
0.91
Price X volume
2.02M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.63 | - | Par |
| Ent. to Revenue | 14.41 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.48 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 75.07 | - | Par |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 112.28M | - | Emerging |
